The Immunization Partnership

Analysis

The Immunization Partnership is a registered charity in United States, based in Houston, TX. It received its IRS tax-exemption ruling in February 2002, 24 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending September 2023, The Immunization Partnership reported income of $1.3m and spending of $1.5m, spending 116% of what it took in. Across the 5 years on record, from September 2019 to September 2023, income grew from $1.2m to $1.3m (+3.4%), an average of +0.8% a year. The sharpest change came in the year to September 2023, when income rose by 51%. Over the whole period it spent 96% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, The Immunization Partnership sits at the 67th percentile: it is larger than about 67% of them. Against every charity in United States with reported income it ranks in the 82nd percentile, and in the 86th percentile within TX. Charities of a similar size with the same main cause include Oxalosis and Hyperoxaluria Foundation ($1.3m), National Consortium of Breast Centers Inc ($1.3m) and Friends of the Children - He Sapa ($1.3m).

On its Form 990 for the period ending September 2023, revenue came from contributions and grants 99% of the total. Compensation of current officers, directors and key employees was $388k (26% of expenses). Other salaries and wages came to $432k. At year end it held assets of $1.3m against liabilities of $85k, net assets of $1.3m. It reported 12 employees.